These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29122439)

  • 21. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs.
    Fenaux M; Opriessnig T; Halbur PG; Elvinger F; Meng XJ
    J Virol; 2004 Jun; 78(12):6297-303. PubMed ID: 15163723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the use of non-pathogenic porcine circovirus type 1 as a vaccine delivery virus vector to express antigenic epitopes of porcine reproductive and respiratory syndrome virus.
    Piñeyro PE; Kenney SP; Giménez-Lirola LG; Opriessnig T; Tian D; Heffron CL; Meng XJ
    Virus Res; 2016 Feb; 213():100-108. PubMed ID: 26555162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of porcine circovirus type 1 detected in Rotarix vaccine.
    Baylis SA; Finsterbusch T; Bannert N; Blümel J; Mankertz A
    Vaccine; 2011 Jan; 29(4):690-7. PubMed ID: 21093497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular and infectivity studies of porcine circovirus in vaccines.
    McClenahan SD; Krause PR; Uhlenhaut C
    Vaccine; 2011 Jun; 29(29-30):4745-53. PubMed ID: 21569811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative efficacy of experimental inactivated and live-attenuated chimeric porcine circovirus (PCV) 1-2b vaccines derived from PCV1 and PCV2b isolates originated in China.
    Li J; Yu T; Wang X; Zhou J; Gao R; Zhang F; Gao X; Gao S; Liu X
    Virol J; 2015 Jul; 12():113. PubMed ID: 26220290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shedding of porcine circovirus into colostrum of sows.
    Shibata I; Okuda Y; Kitajima K; Asai T
    J Vet Med B Infect Dis Vet Public Health; 2006 Aug; 53(6):278-80. PubMed ID: 16907959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Use of Bayesian Hierarchical Logistic Regression in the Development of a Modular Viral Inactivation Claim.
    Banton D; Vacante D; Bulthuis B; Goldstein J; Wineburg M; Schreffler J
    PDA J Pharm Sci Technol; 2019; 73(6):552-561. PubMed ID: 31101710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Construction of molecular clone of chimeric porcine circovirus(PCV1-2) and identification of its infectivity].
    Cao SB; Sun MX; Liu XQ; Liu XW; Chen HC
    Wei Sheng Wu Xue Bao; 2006 Feb; 46(1):158-61. PubMed ID: 16579487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virus removal capacity at varying ionic strength during nanofiltration of AlphaNine® SD.
    Jorba N; Shitanishi KT; Winkler CJ; Herring SW
    Biologicals; 2014 Sep; 42(5):290-3. PubMed ID: 24999080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggregate Removal Nanofiltration of Human Serum Albumin Solution Using Nanocellulose-Based Filter Paper.
    Wu L; Mantas A; Gustafsson S; Manukyan L; Mihranyan A
    Biomedicines; 2020 Jul; 8(7):. PubMed ID: 32668723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyethyleneimine-modified resins effectively remove porcine circovirus and cellular prion protein.
    Yunoki M; Urayama T; Aoyama S; Okaniwa N; Sakai K; Uchida E; Ikuta K; Yamaguchi T
    J Virol Methods; 2021 Aug; 294():114181. PubMed ID: 33984395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proceedings of the 2017 Viral Clearance Symposium, Session 2.1: DSP Unit Operations-Virus Filtration/Inactivation.
    Kreil TR; Roush D
    PDA J Pharm Sci Technol; 2018; 72(5):470-478. PubMed ID: 30030356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Productive infection of human hepatocellular carcinoma cells by porcine circovirus type 1.
    Beach NM; Córdoba L; Kenney SP; Meng XJ
    Vaccine; 2011 Oct; 29(43):7303-6. PubMed ID: 21742002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virus removal studies using nanofiltration membranes.
    O'Grady J; Losikoff A; Poiley J; Fickett D; Oliver C
    Dev Biol Stand; 1996; 88():319-26. PubMed ID: 9119156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serologic response to porcine circovirus type 1 (PCV1) in infants vaccinated with the human rotavirus vaccine, Rotarix™: A retrospective laboratory analysis.
    Han HH; Karkada N; Jayadeva G; Dubin G
    Hum Vaccin Immunother; 2017 Jan; 13(1):237-244. PubMed ID: 27657348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Robustness of nanofiltration for increasing the viral safety margin of biological products.
    Caballero S; Diez JM; Belda FJ; Otegui M; Herring S; Roth NJ; Lee D; Gajardo R; Jorquera JI
    Biologicals; 2014 Mar; 42(2):79-85. PubMed ID: 24485384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Removal of small nonenveloped viruses by antibody-enhanced nanofiltration during the manufacture of plasma derivatives.
    Kreil TR; Wieser A; Berting A; Spruth M; Medek C; Pölsler G; Gaida T; Hämmerle T; Teschner W; Schwarz HP; Barrett PN
    Transfusion; 2006 Jul; 46(7):1143-51. PubMed ID: 16836561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel chimeric porcine circovirus (PCV) with the capsid gene of the emerging PCV2b subtype cloned in the genomic backbone of the non-pathogenic PCV1 is attenuated in vivo and induces protective and cross-protective immunity against PCV2b and PCV2a subtypes in pigs.
    Beach NM; Ramamoorthy S; Opriessnig T; Wu SQ; Meng XJ
    Vaccine; 2010 Dec; 29(2):221-32. PubMed ID: 21044670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and epitope mapping of monoclonal antibodies recognizing N-terminus of Rep of porcine circovirus type 2.
    Meng T; Jia Q; Liu S; Karuppannan AK; Chang CC; Kwang J
    J Virol Methods; 2010 May; 165(2):222-9. PubMed ID: 20152863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogen Safety of a New Intravenous Immune Globulin 10% Liquid.
    Radomski KU; Lattner G; Schmidt T; Römisch J
    BioDrugs; 2017 Apr; 31(2):125-134. PubMed ID: 28236170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.